(b)(4).Internal file number - (b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information #: in the absence of a reported part number, the udi cannot be calculated.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported device could not be conducted because the part number was not provided.The reported patient effect of ventricular fibrillation is listed in the xience prime, everolimus eluting coronary stent system, instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
It was reported the patient presented with an acute myocardial infarction of the anterior wall.To clear the coronary artery occlusion, according to the degree of stenosis and vessel diameter, the xience prime stent was selected and implanted.The second day after operation the patient suddenly lost consciousness and experienced ventricular fibrillation.Defibrillation and artificial respiration were provided and an intra-aortic balloon pump (iabp) was placed.No additional information was provided.
|